NCT06304597 2024-03-12
PREDICT
University Medical Center Groningen
Phase 1 Unknown
Clinical Trials
5 trialsNCT03799744 2022-03-28
Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma
Institut Català d'Oncologia
Phase 1 Unknown
NCT05157542 2021-12-15
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
Sichuan Cancer Hospital and Research Institute
Phase 1 Unknown
NCT05008861 2021-08-17
Gut Microbiota Reconstruction for NSCLC Immunotherapy
Shanghai Zhongshan Hospital
Phase 1 Unknown
NCT03283943 2018-07-11
PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
British Columbia Cancer Agency
Phase 1 Unknown